Today: 10 June 2026
Salesforce (CRM) stock ticks up after hours as AI jitters fade — Feb. 25 earnings are the next test

Salesforce (CRM) stock ticks up after hours as AI jitters fade — Feb. 25 earnings are the next test

New York, February 6, 2026, 18:37 EST — After-hours

  • Shares climbed roughly 0.8% after hours, following a turbulent week for software names.
  • Software stocks are being revalued as traders react to chatter that rapid AI advances might pressure legacy offerings.
  • Salesforce will release both its quarterly and full-year numbers on February 25.

Salesforce Inc climbed 0.8% to $191.35 after hours Friday. Shares had earlier swung from $187.29 to $194.52 during the session. Extended-hours trading runs outside the regular 9:30 a.m. to 4 p.m. ET window.

After U.S. stocks bounced late in the week, software shares finally managed to catch a bid. The Dow pushed past 50,000 for the first time. The S&P 500 Software & Services index climbed 2.4%, halting a seven-day slide, yet still ended the week off nearly 8%—its sharpest weekly drop since March 2020. “This trade has been volatile,” said Ross Mayfield, investment strategy analyst at Baird. Reuters

Salesforce set February 25 as the date for its next earnings update. The company plans to announce fourth-quarter and full-year fiscal 2026 numbers after markets close, with a conference call on tap for 5 p.m. ET.

The date comes after what traders have started to call “software-mageddon,” a period marked by a rough reset for software-as-a-service, or SaaS, names as concerns mount that new AI products could hit demand and squeeze margins. On Thursday, the S&P 500 software and services index slid 4.6%, putting it on pace for a nearly $1 trillion drop in market capitalization since January 28. Salesforce shares lost 4.7%, while ServiceNow tumbled 7.6%. “I would classify this as a sell-everything mindset at this point,” said Dave Harrison Smith, chief investment officer and head of technology investing at Bailard. Reuters

Jitters have followed a steady stream of fresh AI launches. On Thursday, Anthropic rolled out an updated AI model, Claude Opus 4.6, touting it as a step up. The company also showed off early tests of longer, multi-step tasks handled by autonomous agents. One executive described the goal: bridge AI with older software systems to boost their utility.

Some investors aren’t reading the selloff as a final judgment. Wedbush’s Dan Ives described the week’s drop as a “garage sale,” insisting Salesforce “is still a long-term winner of the AI Revolution.” He highlighted how the company is integrating AI tools into its main lineup. Business Insider

Salesforce’s bread and butter is customer relationship management software—business that lives or dies by IT spending and contract renewals. Right now, the question is simple: will AI turn into a premium, revenue-boosting add-on, or just another must-have feature clients expect without paying extra for?

Shares are tracking alongside the broader sector. Salesforce tends to get lumped with other enterprise software names—Microsoft, Workday, ServiceNow. All of them have been volatile lately, as investors keep revisiting what counts as “defensive” in a market dominated by fresh AI headlines.

Still, risks remain. Should customers rein in spending or if investors worry that AI could erode pricing power in subscription software, the rally could evaporate quickly. A single cautious forecast might be enough to trigger another round of selling.

Salesforce’s numbers hit after the bell on February 25. Investors want clues about demand, management’s angle on AI-fueled revenue, and guidance—will it cool the argument roiling the tape this week, or add fuel?

Stock Market Today

  • MindWalk Launches ReefIQ for Enhanced AI-Driven Drug Discovery
    June 10, 2026, 9:49 AM EDT. MindWalk Holdings Corp. (NASDAQ: HYFT) introduced ReefIQ™, a biological context layer designed to unify fragmented drug discovery data for AI analysis. The technology integrates diverse biological information such as sequences, structures, and assay results into a governed, queryable network. This enables MindWalk's LensAI tool and client-selected models to perform more accurate hypothesis generation and target discovery. By preserving data provenance and program history, ReefIQ aims to enhance trust and efficiency in regulated drug development environments. CEO Dr. Jennifer Bath emphasized that ReefIQ closes the data gaps in biological context, crucial for reliable AI-driven insights in life sciences.

Latest articles

Rigetti Computing Stock Falls as Sale Notice Tests $100 Million Quantum Rally

Rigetti Computing Stock Falls as Sale Notice Tests $100 Million Quantum Rally

10 June 2026
Rigetti Computing plunged 9.55% to $19.69 Tuesday and dipped further premarket after director Ray O. Johnson filed to sell 122,188 shares worth $2.6 million, testing investor confidence following a recent rally on news of a potential $100 million U.S. Commerce Department quantum-computing award, with traders watching for binding funding terms amid ongoing volatility.
PATH slips again, investors keep questioning AI automation bet

PATH slips again, investors keep questioning AI automation bet

10 June 2026
UiPath shares slid 3.76% to $10.75 and dropped another 1.49% pre-market as investors focused on slowing annual recurring revenue growth—up 12% to $1.901 billion versus 17% revenue growth—raising doubts about AI automation’s impact on recurring sales; second-quarter ARR guidance of $1.929–$1.934 billion is now the key number for PATH’s stock direction.
Western Digital stock jumps nearly 9% — WDC rally turns on targets, AI storage talk
Previous Story

Western Digital stock jumps nearly 9% — WDC rally turns on targets, AI storage talk

Seagate (STX) stock jumps nearly 6% as Citi hikes target — what to watch next week
Next Story

Seagate (STX) stock jumps nearly 6% as Citi hikes target — what to watch next week

Go toTop